Genelux reprices employee stock options to $3.33 from up to $22.40; covers 2.7M shares

GENELUX Corp

Exercise price reduced to $3.33 for eligible options with prior range $6.00–$22.40 per share.
Repricing covers approximately 2,715,583 shares under 2009/2019/2022 equity plans; exec holdings included.
CEO Thomas Zindrick holds 1,355,940 repriced options; other officers listed with 8,333–272,652 shares.
No changes for non-employee directors or 2023 inducement plan options; original vesting and expiry unchanged.
2025 annual meeting: Zindrick and Tyree re-elected as Class III directors; Weinberg & Company ratified as auditor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.